Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05260021
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:15.475097+00:00
Published At
2025-09-26T00:00:00+00:00
Record Updated At
2025-09-26
Results Posted At
2025-09-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Type2 Diabetes", "Diabetes Mellitus", "Diabetes Mellitus, Type 2", "T2D", "T2DM (Type 2 Diabetes Mellitus)", "Glucose Metabolism Disorders", "Endocrine System Diseases", "Metabolic Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-09-26"
protocolSection.identificationModule.nctId
"NCT05260021"
protocolSection.identificationModule.officialTitle
"A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-09-26"

Study condition terms

  • Type2 Diabetes (protocolSection.conditionsModule.conditions)
  • Diabetes Mellitus (protocolSection.conditionsModule.conditions)
  • Diabetes Mellitus, Type 2 (protocolSection.conditionsModule.conditions)
  • T2D (protocolSection.conditionsModule.conditions)
  • T2DM (Type 2 Diabetes Mellitus) (protocolSection.conditionsModule.conditions)
  • Glucose Metabolism Disorders (protocolSection.conditionsModule.conditions)
  • Endocrine System Diseases (protocolSection.conditionsModule.conditions)
  • Metabolic Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.